BioRestorative Therapies (NASDAQ:BRTX – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.07, Zacks reports. BioRestorative Therapies had a negative net margin of 2,697.08% and a negative return on equity of 98.49%. The firm had revenue of $0.50 million for the quarter, compared to analyst estimates of $0.48 million.
BioRestorative Therapies Trading Down 1.1 %
BRTX stock traded down $0.02 during mid-day trading on Friday, hitting $1.81. 21,475 shares of the company were exchanged, compared to its average volume of 666,632. The firm has a fifty day simple moving average of $1.97 and a 200 day simple moving average of $1.72. The company has a market capitalization of $12.53 million, a PE ratio of -1.18 and a beta of 64.37. BioRestorative Therapies has a twelve month low of $1.03 and a twelve month high of $2.55.
BioRestorative Therapies Company Profile
See Also
- Five stocks we like better than BioRestorative Therapies
- Want to Profit on the Downtrend? Downtrends, Explained.
- MarketBeat Week in Review – 03/24 – 03/28
- How to Use the MarketBeat Dividend Calculator
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What Do S&P 500 Stocks Tell Investors About the Market?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
